UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Inhibition of IκB Kinase Subunit 2 in Cutaneous T-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents

Clinical cancer research, 2008-02, Vol.14 (3), p.901-911

2008

Volltextzugriff (PDF)

Interleukin-6 attenuates the development of experimental diabetes-related neuropathy

Neuropathology, 2006-02, Vol.26 (1), p.32-42

2006

Volltextzugriff (PDF)

AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in jurkat leukemic cells

Oncogene, 2003-11, Vol.22 (50), p.8187-8194

2003

Volltextzugriff (PDF)

Canonical Nuclear Factor κB Pathway Inhibition Blocks Myeloma Cell Growth and Induces Apoptosis in Strong Synergy with TRAIL

Clinical cancer research, 2007-10, Vol.13 (20), p.6010-6018

2007

Volltextzugriff (PDF)

Human Cytomegalovirus Stimulates Cellular IKK2 Activity and Requires the Enzyme for Productive Replication

Journal of Virology, 2004-03, Vol.78 (6), p.3190-3195

2004

Volltextzugriff (PDF)

Crystal structure of inhibitor of κB kinase β

Nature (London), 2011-04, Vol.472 (7343), p.325-330

2011

Volltextzugriff (PDF)

Mechanisms of interleukin-6 protection against ischemia–reperfusion injury in rat liver

Cytokine (Philadelphia, Pa.), 2006-05, Vol.34 (3), p.131-142

2006

Volltextzugriff (PDF)

Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells

Blood, 2005-01, Vol.105 (2), p.804-811

2005

Volltextzugriff (PDF)

Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

Cancer chemotherapy and pharmacology, 2008-11, Vol.62 (6), p.995-1007

2008

Volltextzugriff (PDF)

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

Molecular and cellular neuroscience, 2004-02, Vol.25 (2), p.301-311

2004

Volltextzugriff (PDF)

Characterization of the Major Histocompatibility Complex Class II Binding Site on LAG-3 Protein

Proceedings of the National Academy of Sciences - PNAS, 1997-05, Vol.94 (11), p.5744-5749

1997

Volltextzugriff (PDF)

NF‐κB inhibition triggers death of imatinib‐sensitive and imatinib‐resistant chronic myeloid leukemia cells including T315I Bcr‐Abl mutants

International journal of cancer, 2009-07, Vol.125 (2), p.308-317

2009

Volltextzugriff (PDF)

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

Molecular and cellular neuroscience, 2004-02, Vol.25 (2), p.301-311

2004

Volltextzugriff (PDF)

Targeting NF‐κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth

British journal of haematology, 2007-07, Vol.138 (2), p.160-168

2007

Volltextzugriff (PDF)

Crystal structure of inhibitor of [kappa]B kinase [beta]

Nature (London), 2011-04, Vol.472 (7343), p.325

2011

Volltextzugriff (PDF)

Lymphocyte activation gene‐3 induces tumor regression and antitumor immune responses

European journal of immunology, 1999-12, Vol.29 (12), p.3867-3876

1999

Volltextzugriff (PDF)

Soluble Interleukin-6 (IL-6) Receptor/IL-6 Fusion Protein Enhances in Vitro Differentiation of Purified Rat Oligodendroglial Lineage Cells

Molecular and cellular neuroscience, 2002-12, Vol.21 (4), p.602-615

2002

Volltextzugriff (PDF)

Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome

The European journal of neuroscience, 2001-12, Vol.14 (11), p.1753-1761

2001

Volltextzugriff (PDF)

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.97-105

2011

Volltextzugriff (PDF)

IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy

Cytokine (Philadelphia, Pa.), 2008-06, Vol.42 (3), p.372-378

2008

Volltextzugriff (PDF)

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868

Cancer chemotherapy and pharmacology, 2011-07, Vol.68 (1), p.97-105

2011

Volltextzugriff (PDF)

An Adiponectin-Like Molecule with Antidiabetic Properties

Endocrinology (Philadelphia), 2009-10, Vol.150 (10), p.4493-4501

2009

Volltextzugriff (PDF)

Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL

Clinical cancer research, 2007-10, Vol.13 (20), p.6010-6018

2007

Volltextzugriff (PDF)

Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents

Clinical cancer research, 2008-02, Vol.14 (3), p.901

2008

Volltextzugriff (PDF)

Inhibition of IκB Kinase Subunit 2 in CutaneousT-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents

Clinical cancer research, 2008, Vol.14 (3), p.901-911

2008

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(60)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(33)
Humans
(25)
Animals
(22)
Biological And Medical Sciences
(18)
Medical Sciences
(11)
Life Sciences
(10)
Rats
(10)
Fundamental And Applied Biological Sciences. Psychology
(8)
Mice
(8)
Apoptosis
(7)
Cell Line
(7)
Immunology
(7)
Interleukin-6 - Pharmacology
(7)
Male
(7)
Antineoplastic Agents
(6)
Apoptosis - Drug Effects
(6)
Cell Biology
(6)
Cell Line, Tumor
(6)
Female
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of IκB Kinase Subunit 2 in Cutaneous T-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents

Interleukin-6 attenuates the development of experimental diabetes-related neuropathy

AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in jurkat leukemic cells

Canonical Nuclear Factor κB Pathway Inhibition Blocks Myeloma Cell Growth and Induces Apoptosis in Strong Synergy with TRAIL

Human Cytomegalovirus Stimulates Cellular IKK2 Activity and Requires the Enzyme for Productive Replication

Crystal structure of inhibitor of κB kinase β

Mechanisms of interleukin-6 protection against ischemia–reperfusion injury in rat liver

Targeting NF-κB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells

Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

Characterization of the Major Histocompatibility Complex Class II Binding Site on LAG-3 Protein

NF‐κB inhibition triggers death of imatinib‐sensitive and imatinib‐resistant chronic myeloid leukemia cells including T315I Bcr‐Abl mutants

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices

Targeting NF‐κB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth

Crystal structure of inhibitor of [kappa]B kinase [beta]

Lymphocyte activation gene‐3 induces tumor regression and antitumor immune responses

Soluble Interleukin-6 (IL-6) Receptor/IL-6 Fusion Protein Enhances in Vitro Differentiation of Purified Rat Oligodendroglial Lineage Cells

Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868

IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868

An Adiponectin-Like Molecule with Antidiabetic Properties

Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL

Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents

Inhibition of IκB Kinase Subunit 2 in CutaneousT-Cell Lymphoma Down-Regulates Nuclear Factor-κB Constitutive Activation, Induces Cell Death, and Potentiates the Apoptotic Response to Antineoplastic Chemotherapeutic Agents

Suchergebnisse filtern